Global Adult and Adolescent Vaccines Market Size By Type (Seasonal Vaccines, Travel Vaccines), By Application (Adult, Adolescent), By Region, And Segment Forecasts, 2023 to 2032

The Global Adult and Adolescent Vaccines Market was valued at USD 23.6 billion in 2023 and is projected to reach USD 45.2 billion by 2031, growing at a CAGR of 8.3% during the forecast period from 2023 to 2031. This growth is driven by increasing awareness regarding vaccine-preventable diseases, rising healthcare expenditure, and global immunization initiatives targeting adolescents and adults. The surge in infectious diseases such as influenza, HPV, and hepatitis, along with booster dose requirements and catch-up immunization schedules, are major contributors to market expansion.

Drivers:

1. Rising Incidence of Vaccine-Preventable Diseases:

The global burden of diseases like influenza, meningitis, HPV, and shingles among adult and adolescent populations is prompting greater demand for vaccines. National health organizations are increasing efforts to encourage adult and adolescent immunization programs.

2. Government and Global Health Initiatives:

Programs by WHO, CDC, and GAVI support immunization drives, particularly for underserved adult populations. Policies encouraging adult booster doses and catch-up immunization have boosted vaccine uptake significantly.

3. Advances in Vaccine Development:

Modern technologies such as mRNA vaccines, viral vector platforms, and recombinant DNA are enhancing efficacy and reducing production time, expanding the pipeline for adult and adolescent-targeted vaccines.

Restraints:

1. Vaccine Hesitancy and Misinformation:

Public skepticism around vaccine safety, particularly among adults, continues to be a significant challenge. Misinformation spread via digital platforms contributes to hesitancy in certain regions.

2. Limited Access in Low-Income Countries:

While child vaccination programs are better funded globally, adult and adolescent vaccination often lacks consistent infrastructure and financial support in many developing regions.

Opportunity:

1. Emerging Markets and Aging Populations:

The growth of aging demographics and healthcare reforms in emerging economies present strong opportunities. Expanding vaccination coverage among adults aged 50+ can significantly drive revenue.

2. Expansion of Preventive Healthcare Models:

With a shift towards preventive medicine, health insurers and providers are incorporating adult vaccines into routine care plans, increasing patient compliance and creating consistent demand.

Market by System Type Insights:

Based on vaccine type, the Influenza Vaccines segment held the largest market share in 2023 due to annual seasonal vaccination campaigns and rising global influenza outbreaks. However, HPV and Shingles Vaccines are projected to witness the highest CAGR, fueled by increasing adoption among adolescents and older adults respectively.

Market by End-use Insights:

Hospitals and Clinics dominated the end-use segment in 2023, accounting for over 50% of total revenue. Their critical role in government-funded immunization programs and ease of access make them primary vaccination sites. Pharmacies are also gaining traction, especially in developed countries, due to convenience and expanded pharmacist immunization roles.

Market by Regional Insights:

North America led the global market in 2023, thanks to high awareness levels, favorable reimbursement policies, and robust healthcare infrastructure. Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, with initiatives in countries like India and China focusing on adult immunization and improved vaccine delivery systems.

Competitive Scenario:

Key players in the global adult and adolescent vaccines market include Pfizer Inc., GlaxoSmithKline plc, Sanofi, Merck & Co., Inc., Moderna, Inc., CSL Limited, AstraZeneca plc, Johnson & Johnson, Bharat Biotech, and Serum Institute of India. These companies are investing heavily in R&D, licensing partnerships, and geographic expansion.

In 2023, Pfizer launched a combined pneumococcal vaccine for adults, reducing the need for multiple doses.

Moderna is advancing adult-targeted mRNA vaccines beyond COVID-19, focusing on RSV and cytomegalovirus (CMV).

GSK announced expanded production of its shingles vaccine to meet rising demand across Europe and Asia.

Scope of Work – Global Adult and Adolescent Vaccines Market

Report Metric Details

Market Size (2023) USD 23.6 billion

Projected Market Size (2031) USD 45.2 billion

CAGR (2023–2031) 8.3%

Market Segments By Vaccine Type (Influenza, HPV, Hepatitis, Others), By End-use, By Region

Growth Drivers Rising disease incidence, public health initiatives, vaccine innovation

Opportunities Expansion in emerging markets, preventive healthcare adoption

Key Market Developments:

June 2023: Sanofi launched a new hexavalent adult vaccine combining diphtheria, tetanus, pertussis, hepatitis B, polio, and Hib, aimed at simplifying adult booster immunization schedules.

August 2023: Johnson & Johnson announced strategic collaborations in Asia-Pacific to expand access to HPV vaccines among adolescent girls.

January 2024: Moderna secured FDA breakthrough designation for its investigational mRNA vaccine targeting CMV, a major concern among pregnant women and immunocompromised adults.

FAQs:

1) What is the current market size of the Global Adult and Adolescent Vaccines Market?

The market was valued at USD 23.6 billion in 2023.

2) What is the major growth driver of the Global Adult and Adolescent Vaccines Market?

The rising incidence of vaccine-preventable diseases and global immunization initiatives targeting adults and adolescents are key growth drivers.

3) Which is the largest region during the forecast period in the Global Adult and Adolescent Vaccines Market?

North America is expected to remain the largest regional market due to strong healthcare infrastructure and vaccination coverage.

4) Which segment accounted for the largest market share in Global Adult and Adolescent Vaccines Market?

The Influenza Vaccines segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Adult and Adolescent Vaccines Market?

Major players include Pfizer Inc., Sanofi, GSK, Merck & Co., Moderna, AstraZeneca, and the Serum Institute of India.